C81.17
Nodular sclerosis Hodgkin lymphoma, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Nodular sclerosis Hodgkin lymphoma is a specific type of Hodgkin lymphoma, which is a cancer affecting the lymphatic system. When it involves the spleen, it can impact the organ that plays a vital role in immune response and blood filtration. This condition typically occurs in young adults and is characterized by the presence of distinctive nodular structures seen under the microscope. Recognizing this disease is crucial for timely diagnosis and treatment planning.
Causes & Symptoms
Clinical Causes: The exact cause of Hodgkin lymphoma, including the nodular sclerosis subtype, remains unclear, but certain factors may increase risk. Age: Most common in young adults aged 15-35 and in older adults over 55. Family history: A family history of Hodgkin or other lymphomas may increase risk. Immune system conditions: Suppressed immune function due to HIV/AIDS or autoimmune diseases. Infections: A history of Epstein-Barr Virus (EBV) infection has been linked to Hodgkin lymphoma. Environmental factors: Exposure to certain chemicals or radiation may play a role.
Key Symptoms: Swollen lymph nodes in the neck, armpits, or groin. Persistent fever and night sweats. Unexplained weight loss. Itching all over the body. Fatigue and weakness. Abdominal discomfort or pain if the spleen is enlarged. In cases involving the spleen, possible symptoms include fullness or discomfort in the upper left abdomen and a feeling of fullness without eating much.
Diagnostic & Treatment
Diagnosis Path: Medical history assessment and physical exam to identify swollen lymph nodes or spleen enlargement. Imaging tests such as CT scans or PET scans to determine the extent and locations of affected lymph nodes and organs. Lymph node biopsy: A sample tissue is examined microscopically to identify characteristic Reed-Sternberg cells and confirm Hodgkin lymphoma. Blood tests to assess overall health and organ function. Bone marrow biopsy in some cases to check for cancer spread.
Treatment Protocols: Chemotherapy: The primary treatment for Hodgkin lymphoma, involving drugs that kill cancer cells. Radiation therapy: Targeted radiation may be used to address localized disease, especially in the lymph nodes or spleen. Stem cell transplantation: Considered in cases where the disease has relapsed or is resistant to initial treatment. Immunotherapy: Emerging treatments that help the immune system recognize and fight cancer cells. Surgical removal of the spleen (splenectomy): May be considered if the spleen is significantly involved or causing symptoms, but is less common as a primary treatment.
Clinical Advice & FAQs
Billing Guidance
Is C81.17 a billable ICD-10 code?
Yes, C81.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.17?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference